Prestige Biologics is a Manufacturer/Innovator, Contract Service company operating in the pharmaceutical industry.
PRESTIGE BIOLOGICS is a CDMO service provider in the production of biological drug substances (DS) derived from mammalian cells. We have four plants with a manufacturing capacity of 154,000L, certified by EU-GMP. We provide end-to-end service, drug products (DP) as well. Plants 1, 2, and 3 are equipped with single-use technology, while Plant 4 utilizes an advanced hybrid system.
Company type
Manufacturer/Innovator, Contract Service
Products and services
Biopharmaceuticals, Contract Services – Contract Services, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services, Contract Manufacturing, Clinical Research, Clinical Trials Phase
Markets
North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Prestige Biologics on Facebook
Connect with Prestige Biologics on LinkedIn
Address
Prestige Biologics, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea, 138567
